|Podcasts|April 29, 2021
Episode 81: Cancer Research Amid COVID
Author(s)Elaine Quilici
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
Advertisement
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, talks about the challenges and silver linings of continuing cancer research during the pandemic.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
How Does FDA's Single Trial Decision Change The Risk Calculus for Sponsors
3
What is Shadow AI and How is it Impacting Pharma Companies?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5